CSIMarket



Johnson and Johnson  (JNJ)
Other Ticker:  
 
 

JNJ's Operating Income Growth by Quarter and Year

Johnson And Johnson's Operating Income results by quarter and year




JNJ Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter January - 4,892.00 4,075.00 4,238.00
III Quarter October - 5,706.00 5,633.00 5,820.00
II Quarter July - 6,202.00 3,990.00 5,353.00
I Quarter April 5,748.00 6,595.00 5,788.00 4,403.00
FY   5,748.00 23,395.00 19,486.00 19,814.00



JNJ Operating Income first quarter 2022 Y/Y Growth Comment
Johnson And Johnson reported fall in Operating Income in the first quarter 2022 by -12.84% to $ 5,748.00 millions, from the same quarter in 2021.
The decline in the first quarter 2022 Johnson And Johnson's Operating Income compares unfavorably to the Company's average Operating Income growth of 3.72%.

Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 27 other companies have achieved higher Operating Income growth. While Johnson And Johnson' s Operating Income decrease of -12.84% ranks overall at the positon no. 1582 in the first quarter 2022.

Explain Operating Income growth


JNJ Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter January - 20.05 % -3.85 % 2.02 %
III Quarter October - 1.3 % -3.21 % 29.51 %
II Quarter July - 55.44 % -25.46 % -2.03 %
I Quarter April -12.84 % 13.94 % 31.46 % -22.56 %
FY   - 20.06 % -1.66 % 0.08 %

Financial Statements
Johnson And Johnson's first quarter 2022 Operating Income $ 5,748.00 millions JNJ's Income Statement
Johnson And Johnson's first quarter 2021 Operating Income $ 6,595.00 millions Quarterly JNJ's Income Statement
New: More JNJ's historic Operating Income Growth >>


JNJ Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter January - -14.27 % -27.66 % -27.18 %
III Quarter October - -8 % 41.18 % 8.72 %
II Quarter July - -5.96 % -31.06 % 21.58 %
I Quarter April 17.5 % 61.84 % 36.57 % 5.99 %
FY (Year on Year)   - 20.06 % -1.66 % 0.08 %




Operating Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #28
Healthcare Sector #107
Overall #1582

Operating Income Y/Y Growth Statistics
High Average Low
66.47 % 3.72 % -100 %
(Jan 01 2017)   (Jan 01 2012)
Operating Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #28
Healthcare Sector #107
Overall #1582
Operating Income Y/Y Growth Statistics
High Average Low
66.47 % 3.72 % -100 %
(Jan 01 2017)   (Jan 01 2012)

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Johnson And Johnson's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
107.52 % 4.32 % -100 %
(Apr 01 2018)  


JNJ's I. Quarter Q/Q Operating Income Comment
Johnson and Johnson achieved in the I. Quarter 2022 above company average sequential Operating Income jump of 17.5%, to $ 5,748.00 millions, from $4,892.00 millions in the forth quarter.

Within Major Pharmaceutical Preparations industry 19 other companies have achieved higher Operating Income quarter on quarter growth. While Johnson And Johnson's Operating Income growth quarter on quarter, overall rank is 588.


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #20
Healthcare Sector #50
Overall #588
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #20
Healthcare Sector #50
Overall #588
Operating Income Q/Q Growth Statistics
High Average Low
107.52 % 4.32 % -100 %
(Apr 01 2018)  


JNJ's I. Quarter Q/Q Operating Income Comment
Johnson and Johnson achieved in the I. Quarter 2022 above company average sequential Operating Income jump of 17.5%, to $ 5,748.00 millions, from $4,892.00 millions in the forth quarter.

Within Major Pharmaceutical Preparations industry 19 other companies have achieved higher Operating Income quarter on quarter growth. While Johnson And Johnson's Operating Income growth quarter on quarter, overall rank is 588.


Johnson And Johnson's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Apr 03 2022)
12 Months Ending
(Jan 02 2022)
12 Months Ending
(Oct 03 2021)
12 Months Ending
(Jul 04 2021)
12 Months Ending
(Apr 04 2021)
Cumulative Operating Income 12 Months Ending $ 22,548.00 $ 23,395.00 $ 22,578.00 $ 22,505.00 $ 20,293.00
Y / Y Operating Income Growth (TTM) 11.11 % 20.06 % 14.91 % 13.46 % -4.27 %
Year on Year Operating Income Growth Overall Ranking # 1328 # 920 # 1273 # 1313 # 1347
Seqeuential Operating Income Change (TTM) -3.62 % 3.62 % 0.32 % 10.9 % 4.14 %
Seq. Operating Income Growth (TTM) Overall Ranking # 1768 # 901 # 1675 # 1226 # 1434




Cumulative Operating Income growth Comment
Assuming the Johnson And Johnson's fiscal year would have ended in Apr 03 2022, Johnson And Johnson would have reprted above average annual Operating Income increase of 11.11% year on year, of $ 22,548 millions.
This marks a slow-down of the companys growth trends and from the 20.06% improvement in Jan 02 2022.

In the Healthcare sector 86 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 920 to 1328.

Operating Income TTM Q/Q Growth Statistics
High Average Low
10.9 %
0.73 %
-8.4 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 38
Healthcare Sector # 87
Overall # 1328

Operating Income TTM Y/Y Growth Statistics
High Average Low
24.17 %
3.88 %
-16.24 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 38
Sector # 134
S&P 500 # 1768
Cumulative Operating Income growth Comment
Assuming the Johnson And Johnson's fiscal year would have ended in Apr 03 2022, Johnson And Johnson would have reprted above average annual Operating Income increase of 11.11% year on year, of $ 22,548 millions.
This marks a slow-down of the companys growth trends and from the 20.06% improvement in Jan 02 2022.

In the Healthcare sector 86 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 920 to 1328.

Operating Income TTM Q/Q Growth Statistics
High Average Low
10.9 %
0.73 %
-8.4 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 38
Healthcare Sector # 87
Overall # 1328

Operating Income TTM Y/Y Growth Statistics
High Average Low
24.17 %
3.88 %
-16.24 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 38
Sector # 134
S&P 500 # 1768




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
JNJ's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for JNJ's Competitors
Operating Income Growth for Johnson And Johnson's Suppliers
Operating Income Growth for JNJ's Customers

You may also want to know
JNJ's Annual Growth Rates JNJ's Profitability Ratios JNJ's Asset Turnover Ratio JNJ's Dividend Growth
JNJ's Roe JNJ's Valuation Ratios JNJ's Financial Strength Ratios JNJ's Dividend Payout Ratio
JNJ's Roa JNJ's Inventory Turnover Ratio JNJ's Growth Rates JNJ's Dividend Comparisons



Companies with similar Operating Income improvement for the quarter ending Apr 03 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Apr 03 2022
Illumina Inc -4.66%$ -4.663 millions
Masimo Corp-9.01%$ -9.014 millions
Johnson and Johnson-12.84%$ -12.843 millions
Envista Holdings Corporation-15.51%$ -15.512 millions
Ortho Clinical Diagnostics Holdings Plc-17.94%$ -17.944 millions
National Vision Holdings Inc -39.25%$ -39.246 millions
Aveanna Healthcare Holdings Inc -51.31%$ -51.315 millions
Perrigo Company Plc-57.78%$ -57.782 millions
Lakeland Industries Inc.-76.77%$ -76.771 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CISO's Profile

Stock Price

CISO's Financials

Business Description

Fundamentals

Charts & Quotes

CISO's News

Suppliers

CISO's Competitors

Customers & Markets

Economic Indicators

CISO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071